A promising dual-drug targeted delivery system in cancer therapy: nanocomplexes of folate–apoferritin-conjugated cationic solid lipid nanoparticles

References

• Ahmad R, Deng Y, Singh R, Hussain M, Shah MAA, Elingarami S, He N, Sun Y. 2018. Cutting edge protein and carbohydrate-based materials for anticancer drug delivery. J Biomed Nanotechnol. 14(1):20–43.
   PubMed Web of Science ®Google Scholar
• Alqaraghuli J, Gomhor H, Kashanian S, Rafipour R, Mansouri K. 2019. Dopamine-conjugated apoferritin protein nanocage for the dual-targeting delivery of epirubicin. Nanomed J. 6(4):250–257.
   Google Scholar
• Arkan E, Azandaryani AH, Moradipour P, Behbood L. 2018. Biomacromolecular based fibers in nanomedicine: a combination of drug delivery and tissue engineering. CPB. 18(11):909–924.
   Google Scholar
• Azandaryani AH, Kashanian S, Derakhshandeh K. 2017. Folate conjugated hybrid nanocarrier for targeted letrozole delivery in breast cancer treatment. Pharm Res. 34(12):2798–2808.
   PubMed Web of Science ®Google Scholar
• Azandaryani AH, Kashanian S, Tosaramandani TJ. 2019. Recent insights into effective nanomaterials and biomacromolecules conjugation in advanced drug targeting. CPB. 20(7):526–541.
   Google Scholar
• Bayón-Cordero L, Alkorta I, Arana L. 2019. Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs. Nanomaterials (Basel). 9(3):474.
   Google Scholar
• Beik J, Jafariyan M, Montazerabadi A, Ghadimi-Daresajini A, Tarighi P, Mahmoudabadi A, Ghaznavi H, Shakeri-Zadeh A. 2018. The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging: radiation dose reduction and image contrast enhancement. Artif Cells Nanomed Biotechnol. 46(8):1993–2001.
   PubMed Web of Science ®Google Scholar
• Belletti D, Pederzoli F, Forni F, Vandelli MA, Tosi G, Ruozi B. 2017. Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin. Expert Opin Drug Deliv. 14(7):825–840.
   PubMed Web of Science ®Google Scholar
• Blazkova I, Nguyen H, Dostalova S, Kopel P, Stanisavljevic M, Vaculovicova M, Stiborova M, Eckschlager T, Kizek R, Adam V. 2013. Apoferritin modified magnetic particles as doxorubicin carriers for anticancer drug delivery. IJMS. 14(7):13391–13402.
   Google Scholar
• Bouzinab k, Summers h, Stevens MF, Moody CJ, Thomas NR, Gershkovich P, Weston N, Ashford MB, Bradshaw TD, Turyanska L. 2020. Delivery of temozolomide and N3-propargyl analog to brain tumors using an apoferritin nanocage. ACS Appl Mater Interf. 12(11):12609–12617.
   PubMed Web of Science ®Google Scholar
• Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72(1-2):248–254.
   PubMed Web of Science ®Google Scholar
• Chen C, Hu H, Qiao M, Zhao X, Wang Y, Chen K, Chen D. 2015. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier. J Drug Target. 23(4):311–322.
   PubMed Web of Science ®Google Scholar
• Cheng X, Fan K, Wang L, Ying X, Sanders AJ, Guo T, Xing X, Zhou M, Du H, Hu Y, et al. 2020. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer. Cell Death Dis. 11(2):1–13.
   PubMed Web of Science ®Google Scholar
• Crich SG, Cadenazzi M, Lanzardo S, Conti L, Ruiu R, Alberti D, Cavallo F, Cutrin JC, Aime S. 2015. Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells. Nanoscale. 7(15):6527–6533.
   PubMed Web of Science ®Google Scholar
• Danesi R, Fogli S, Gennari A, Conte P, Del TM. 2002. Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. Clin Pharmacokinet. 41(6):431–444.
   PubMed Web of Science ®Google Scholar
• Dostalova S, Vasickova K, Hynek D, Krizkova S, Richtera L, Vaculovicova M, Eckschlager T, Stiborova M, Heger Z, Adam V. 2017. Apoferritin as an ubiquitous nanocarrier with excellent shelf life. IJN. 12:2265–2278.
   Google Scholar
• Dostalova S, Vazzana M, Vaculovicova M, Adam V, Kizek R. 2015. Interaction of nanocarrier apoferritin with cytotoxic drug molecules. J Metallom Nanotechnol. 3:71–80.
   Google Scholar
• Enache M, Toader A, Enache M. 2016. Mitoxantrone-surfactant interactions: a physicochemical overview. Molecules. 21(10):1356.
   Web of Science ®Google Scholar
• Fan K, Cao C, Pan Y, Lu D, Yang D, Feng J, Song L, Liang M, Yan X. 2012. Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nature Nanotech. 7(7):459–464.
   PubMed Web of Science ®Google Scholar
• Fong Y, Chen C-H, Chen J-P. 2017. Intratumoral delivery of doxorubicin on folate-conjugated graphene oxide by in-situ forming thermo-sensitive hydrogel for breast cancer therapy. Nanomaterials. 7(11):388.
   Web of Science ®Google Scholar
• Ghosh S, Mohapatra S, Thomas A, Bhunia D, Saha A, Das G, Jana B, Ghosh S. 2016. Apoferritin nanocage delivers combination of microtubule and nucleus targeting anticancer drugs. ACS Appl Mater Interf. 8(45):30824–30832.
   PubMed Web of Science ®Google Scholar
• Alqaraghuli GJH, Kashanian S, Rafipour R, Mahdavian E, Mansouri K. 2018. Development and characterization of folic acid-functionalized apoferritin as a delivery vehicle for epirubicin against MCF-7 breast cancer cells. Artif Cells Nanomed Biotechnol. 46(sup3):S847–S854.
   PubMedGoogle Scholar
• Gupta Y, Jain A, Jain SK. 2010. Transferrin‐conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharmacy Pharmacol. 59(7):935–940.
   Google Scholar
• Hao J, Tong T, Jin K, Zhuang Q, Han T, Bi Y, Wang J, Wang X. 2017. Folic acid-functionalized drug delivery platform of resveratrol based on pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles. IJN. 12:2279–2292.
   Google Scholar
• Heger Z, Skalickova S, Zitka O, Adam V, Kizek R. 2014. Apoferritin applications in nanomedicine. Nanomedicine. 9(14):2233–2245.
   PubMed Web of Science ®Google Scholar
• Heister E, Neves V, Lamprecht C, Silva SRP, Coley HM, McFadden J. 2012. Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes. Carbon. 50(2):622–632.
   Web of Science ®Google Scholar
• Jain SK, Chaurasiya A, Gupta Y, Jain A, Dagur P, Joshi B, Katoch VM. 2008. Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting. J Microencapsulation. 25(5):289–297.
   PubMed Web of Science ®Google Scholar
• Jose S, Anju S, Cinu T, Aleykutty N, Thomas S, Souto E. 2014. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int J Pharm. 474(1-2):6–13.
   PubMed Web of Science ®Google Scholar
• Kashanian S, Azandaryani AH, Derakhshandeh K. 2011. New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell. Int J Nanomed. 6:2393.
   PubMed Web of Science ®Google Scholar
• Kashanian S, Tarighat FA, Rafipour R, Abbasi-Tarighat M. 2012. Biomimetic synthesis and characterization of cobalt nanoparticles using apoferritin, and investigation of direct electron transfer of Co (NPs)–ferritin at modified glassy carbon electrode to design a novel nanobiosensor. Mol Biol Rep. 39(9):8793–8802.
   PubMed Web of Science ®Google Scholar
• Khademi S, Sarkar S, Shakeri-Zadeh A, Attaran N, Kharrazi S, Ay MR, Ghadiri H. 2018. Folic acid-cysteamine modified gold nanoparticle as a nanoprobe for targeted computed tomography imaging of cancer cells. Mater Sci Eng C. 89:182–193.
   PubMed Web of Science ®Google Scholar
• Kilic MA, Ozlu E, Calis S. 2012. A novel protein-based anticancer drug encapsulating nanosphere: apoferritin-doxorubicin complex. J Biomed Nanotechnol. 8(3):508–514.
   PubMed Web of Science ®Google Scholar
• Kim T-H, Oh J-M. 2016. Dual nutraceutical nanohybrids of folic acid and calcium containing layered double hydroxides. J Solid State Chem. 233:125–132.
   Web of Science ®Google Scholar
• Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H. 2009. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release. 133(3):238–244.
   PubMed Web of Science ®Google Scholar
• Li L, Fang CJ, Ryan JC, Niemi EC, Lebrón JA, Björkman PJ, Arase H, Torti FM, Torti SV, Nakamura MC, et al. 2010. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc Natl Acad Sci USA. 107(8):3505–3510.
   PubMed Web of Science ®Google Scholar
• Lotocki V, Yazdani H, Zhang Q, Gran ER, Nyrko A, Maysinger D, Kakkar A. 2021. Miktoarm star polymers with environment-selective ROS/GSH responsive locations: from modular synthesis to tuned drug release through micellar partial corona shedding and/or core disassembly. Macromol Biosci. 21(2):2000305.
   Web of Science ®Google Scholar
• Ma P, Dong X, Swadley CL, Gupte A, Leggas M, Ledebur HC, Mumper RJ. 2009. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. J Biomed Nanotechnol. 5(2):151–161.
   PubMed Web of Science ®Google Scholar
• Ma N, Liu J, He W, Li Z, Luan Y, Song Y, Garg S. 2017. Folic acid-grafted bovine serum albumin decorated graphene oxide: an efficient drug carrier for targeted cancer therapy. J Colloid Interface Sci. 490:598–607.
   PubMed Web of Science ®Google Scholar
• Mazur A, Litt I, Shorr E. 1950. Chemical properties of ferritin and their relation to its vasodepressor activity. J Biol Chem. 187(2):473–484.
   PubMed Web of Science ®Google Scholar
• Montazerabadi A, Beik J, Irajirad R, Attaran N, Khaledi S, Ghaznavi H, Shakeri-Zadeh A. 2019. Folate-modified and curcumin-loaded dendritic magnetite nanocarriers for the targeted thermo-chemotherapy of cancer cells. Artif Cells Nanomed Biotechnol. 47(1):330–340.
   PubMed Web of Science ®Google Scholar
• Peres-Filho MJ, dos Santos AP, Nascimento TL, de Avila RI, Ferreira FS, Valadares MC, Lima EM. 2018. Antiproliferative activity and VEGF expression reduction in MCF7 and PC-3 cancer cells by paclitaxel and imatinib co-encapsulation in folate-targeted liposomes. AAPS PharmSciTech. 19(1):201–212.
   PubMed Web of Science ®Google Scholar
• Pooja D, Kulhari H, Kuncha M, Rachamalla SS, Adams DJ, Bansal V, Sistla R. 2016. Improving efficacy, oral bioavailability, and delivery of paclitaxel using protein-grafted solid lipid nanoparticles. Mol Pharm. 13(11):3903–3912.
   PubMed Web of Science ®Google Scholar
• Ren Y, Wong SM, Lim L-Y. 2007. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. Bioconjugate Chem. 18(3):836–843.
   PubMed Web of Science ®Google Scholar
• Ridha AA, Kashanian S, Azandaryani AH, Rafipour R, Mahdavian E. 2020. New folate-modified human serum albumin conjugated to cationic lipid carriers for dual targeting of mitoxantrone against breast cancer. CPB. (4):305–315.
   Google Scholar
• Rostami E, Kashanian S, Azandaryani AH. 2014. Preparation of solid lipid nanoparticles as drug carriers  for levothyroxine sodium with in vitro drug delivery kinetic characterization. Mol Biol Rep. 41(5):3521–3527.
   Google Scholar
• Subedi RK, Kang KW, Choi H-K. 2009. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci. 37(3-4):508–513.
   PubMed Web of Science ®Google Scholar
• Xu Y, Asghar S, Gao S, Chen Z, Huang L, Yin L, Ping Q, Xiao Y. 2017. Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor. IJN. 12:7337–7350.
   Google Scholar
• Yao H, Su L, Zeng M, Cao L, Zhao W, Chen C, Du B, Zhou J. 2016. Construction of magnetic-carbon-quantum-dots-probe-labeled apoferritin nanocages for bioimaging and targeted therapy. IJN. 11:4423–4438.
   Web of Science ®Google Scholar
• Zeinizade E, Tabei M, Shakeri-Zadeh A, Ghaznavi H, Attaran N, Komeili A, Ghalandari B, Maleki S, Kamrava SK. 2018. Selective apoptosis induction in cancer cells using folate-conjugated gold nanoparticles and controlling the laser irradiation conditions. Artif Cells Nanomed Biotechnol. 46(sup1):1026–1038.
   PubMed Web of Science ®Google Scholar
• Zhen Z, Tang W, Chen H, Lin X, Todd T, Wang G, Cowger T, Chen X, Xie J. 2013. RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors. ACS. 7(6):4830–4837.
   PubMed Web of Science ®Google Scholar
• Zhou J, Chen S, Sun C, Du Q, Luo P, Du B, Yao H. 2016. A “submunition” dual-drug system based on smart hollow NaYF 4/apoferritin nanocage for upconversion imaging. RSC Adv. 6(40):33443–33454.
   Web of Science ®Google Scholar
• Zhou J, Yao H, Meng L, Sun C, Ye W, Du Q. 2017. A hollow NaGdF4/AFn nanosystem based on “Relay Race” release for therapy. ChemMedChem. 12(15):1191–1200.
   PubMed Web of Science ®Google Scholar